All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
• Eli Lilly and Co., of Indianapolis, said it has met the FDA's requirements for pediatric exclusivity for Cymbalta (duloxetine HCl), gaining an additional six months of U.S. market exclusivity for the drug, which now will expire in December 2013.